208 related articles for article (PubMed ID: 26251132)
21. The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
Patel S; Patel N; Sassoon I; Patel V
Radiother Oncol; 2021 Mar; 156():209-216. PubMed ID: 33385466
[TBL] [Abstract][Full Text] [Related]
22. Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy.
Patel V; McGurk M
Br J Oral Maxillofac Surg; 2017 Apr; 55(3):235-241. PubMed ID: 28027781
[TBL] [Abstract][Full Text] [Related]
23. Can the prophylactic use of pentoxifylline and tocopherol before dental extractions prevent osteoradionecrosis? A systematic review.
Paiva GLA; de Campos WG; Rocha AC; Júnior CAL; Migliorati CA; Dos Santos Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jul; 136(1):33-41. PubMed ID: 36882364
[TBL] [Abstract][Full Text] [Related]
24. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
Hille A; Christiansen H; Pradier O; Hermann RM; Siekmeyer B; Weiss E; Hilgers R; Hess CF; Schmidberger H
Strahlenther Onkol; 2005 Sep; 181(9):606-14. PubMed ID: 16170489
[TBL] [Abstract][Full Text] [Related]
25. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit.
D'Souza J; Lowe D; Rogers SN
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):356-62. PubMed ID: 24480621
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw.
Heifetz-Li JJ; Abdelsamie S; Campbell CB; Roth S; Fielding AF; Mulligan JP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Nov; 128(5):491-497.e2. PubMed ID: 31488389
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
McCaul JA
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):247-52. PubMed ID: 24794269
[TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review.
Banjar A; Patel V; Abed H
Oral Dis; 2023 Jan; 29(1):29-39. PubMed ID: 34695271
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of grade III osteoradionecrosis with mandibular fracture with pentoxifylline, tocopherol and clodronate.
Magremanne M
J Stomatol Oral Maxillofac Surg; 2018 Dec; 119(6):518-522. PubMed ID: 29936237
[TBL] [Abstract][Full Text] [Related]
30. Effects of pentoxifylline and tocopherol on a rat-irradiated jaw model using micro-CT cortical bone analysis.
Nguyen TTH; Eo MY; Seo MH; Myoung H; Kim SM; Lee JH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3443-3452. PubMed ID: 31414224
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.
Arqueros-Lemus M; Mariño-Recabarren D; Niklander S; Martínez-Flores R; Moraga V
Med Oral Patol Oral Cir Bucal; 2023 May; 28(3):e293-e300. PubMed ID: 36641743
[TBL] [Abstract][Full Text] [Related]
32. The management of osteoradionecrosis of the jaws--a review.
Rice N; Polyzois I; Ekanayake K; Omer O; Stassen LF
Surgeon; 2015 Apr; 13(2):101-9. PubMed ID: 25084627
[TBL] [Abstract][Full Text] [Related]
33. Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature.
Breik O; Tocaciu S; Briggs K; Tasfia Saief S; Richardson S
Int J Oral Maxillofac Surg; 2019 Aug; 48(8):1022-1027. PubMed ID: 30981534
[TBL] [Abstract][Full Text] [Related]
34. New perspectives on the conservative management of osteoradionecrosis of the mandible: A literature review.
Costa DA; Costa TP; Netto EC; Joaquim N; Ventura I; Pratas AC; Winckler P; Silva IP; Pinho AC; Sargento IG; Guerreiro FG; Moreira AR
Head Neck; 2016 Nov; 38(11):1708-1716. PubMed ID: 27240248
[TBL] [Abstract][Full Text] [Related]
35. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment.
Lyons A; Ghazali N
Br J Oral Maxillofac Surg; 2008 Dec; 46(8):653-60. PubMed ID: 18562055
[TBL] [Abstract][Full Text] [Related]
36. Pentoxifylline - a review of its use in osteoradionecrosis.
Lyons AJ; Brennan PA
Br J Oral Maxillofac Surg; 2017 Apr; 55(3):230-234. PubMed ID: 28034471
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations.
Futran ND; Trotti A; Gwede C
Laryngoscope; 1997 Mar; 107(3):391-5. PubMed ID: 9121320
[TBL] [Abstract][Full Text] [Related]
38. Significant clinical improvement in radiation-induced lumbosacral polyradiculopathy by a treatment combining pentoxifylline, tocopherol, and clodronate (Pentoclo).
Delanian S; Lefaix JL; Maisonobe T; Salachas F; Pradat PF
J Neurol Sci; 2008 Dec; 275(1-2):164-6. PubMed ID: 18804790
[TBL] [Abstract][Full Text] [Related]
39. Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol.
Dinnoo A; Bidault F; Lassau N; Elmaalouf M; Moya-Plana A; Ruffier A; Janot F; Benmoussa N
J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):286-287. PubMed ID: 31271892
[TBL] [Abstract][Full Text] [Related]
40. Patients' experience and perceived concerns regarding obtaining and taking prescriptions for head and neck osteoradionecrosis.
Willcocks EJ; Lim YBY; Rogers SN
Br J Oral Maxillofac Surg; 2022 May; 60(4):459-464. PubMed ID: 35351326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
